Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 120

Results For "ALS"

7987 News Found

Manipal Hospital launches ‘Oorja’ Support Group for celiac awareness in children
Hospitals | May 19, 2026

Manipal Hospital launches ‘Oorja’ Support Group for celiac awareness in children

Initiative focuses on early diagnosis, gut health awareness and long-term gluten-free care for children with celiac disease


India’s top scientific minds discuss  preparedness against emerging health threats
Policy | May 19, 2026

India’s top scientific minds discuss preparedness against emerging health threats

Discussions during the meeting focused on strengthening India’s preparedness against zoonotic diseases and climate-sensitive health challenges


HLL Lifecare marks diamond jubilee with release of special Rs. 60 commemorative coin
Healthcare | May 19, 2026

HLL Lifecare marks diamond jubilee with release of special Rs. 60 commemorative coin

Union health ministry secretary Punya Salila Srivastava lauds HLL’s six decades of contribution to public healthcare and social development


Zydus Wellness FY26 revenue climbs to Rs. 39.4 billion
Healthcare | May 19, 2026

Zydus Wellness FY26 revenue climbs to Rs. 39.4 billion

Growth driven by strong performance across Sugar Free, RiteBite Max Protein, Everyuth, Glucon-D and Nutralite portfolios


India’s opportunity to build preventive healthcare economy
Opinion | May 19, 2026

India’s opportunity to build preventive healthcare economy

The country’s strength lies not just in technology availability but in adoption behaviour


Cupid shatters FY26 guidance with record 93% revenue jump & 165% profit surge
News | May 19, 2026

Cupid shatters FY26 guidance with record 93% revenue jump & 165% profit surge

Growth was driven by expansion across key business segments, improving efficiencies, and sustained demand across institutional and retail channels


Alivus Life Sciences posts steady FY26 growth as margins surge past guidance
News | May 19, 2026

Alivus Life Sciences posts steady FY26 growth as margins surge past guidance

The company reported free cash flow of Rs. 2,590 Mn for FY26


Bayer’s NUBEQA combo shows 71% drop in risk of progression or death in prostate cancer trial
Clinical Trials | May 19, 2026

Bayer’s NUBEQA combo shows 71% drop in risk of progression or death in prostate cancer trial

Despite the strong results, investigators cautioned that the study has limitations, including its open-label Phase II design, lack of randomization, and reliance on a historical external control arm


FDA expands Enhertu use in early HER2-positive breast cancer
Drug Approval | May 19, 2026

FDA expands Enhertu use in early HER2-positive breast cancer

AstraZeneca highlighted the move as a major step toward earlier intervention in curable disease